Vyvanse / Lisdexamfetamine → 🇦🇺 Australia

Full details

Vyvanse / Lisdexamfetamine restricted; documentation or permits may apply. Quantity guidance for Australia: Up to 3-month personal supply under TGA personal importation scheme. Documentation: Original prescription from licensed physician; Medication in original pharmacy-labelled packaging; Doctor's letter stating medical necessity. Enforcement in Australia carries fines from AUD 444 to AUD 2,664 under Customs Act 1901 s.234; Biosecurity Act 2015 s.535 (ordinary personal cases are handled as civil infringements). Restricted status means compliant carriage is achievable with the right paperwork and quantities; the practical risks are seizure, duty, and delay rather than criminal liability for a good-faith traveller. Arrival checks are carried out by Australian Border Force (ABF); when in doubt use the declare (red) channel — declared goods at worst attract duty or surrender, while undeclared goods attract penalties. Leaving Australia with vyvanse / lisdexamfetamine is a separate question: restricted — Vyvanse (lisdexamfetamine) is a controlled stimulant; personal export from Australia requires prescription documentation and stays within personal-use limits.

Leaving Australia with vyvanse / lisdexamfetamine

Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the Customs (Prohibited Exports) Regulations 1958; Therapeutic Goods Act 1989 framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from Australia; above these limits a TGA export permit for schedule 8 substances above threshold is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.

OFFICIAL SOURCES · VERIFIED 2026-08-22